Back to Search
Start Over
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
- Source :
-
JAMA dermatology [JAMA Dermatol] 2016 Jul 01; Vol. 152 (7), pp. 837-9. - Publication Year :
- 2016
- Subjects :
- Acrylamides adverse effects
Adult
Aged
Child
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Lymphoma, T-Cell, Cutaneous diagnosis
Lymphoma, T-Cell, Cutaneous mortality
Male
Middle Aged
Neoplasm Invasiveness pathology
Neoplasm Recurrence, Local diagnosis
Neoplasm Recurrence, Local mortality
Neoplasm Staging
Piperidines adverse effects
Prognosis
Risk Assessment
Skin Neoplasms diagnosis
Skin Neoplasms mortality
Survival Analysis
Treatment Outcome
Acrylamides therapeutic use
Lymphoma, T-Cell, Cutaneous drug therapy
Neoplasm Recurrence, Local drug therapy
Patient Safety
Piperidines therapeutic use
Skin Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2168-6084
- Volume :
- 152
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- JAMA dermatology
- Publication Type :
- Report
- Accession number :
- 27007550
- Full Text :
- https://doi.org/10.1001/jamadermatol.2016.0401